References
- 1.Adam R.D.: Giardia duodenalis: Biology and Pathogenesis. Clinical Microbiology Reviews. 34(4), e00024–19 (2021) doi:
10.1128/CMR.00024-19
AdamR.D. Giardia duodenalis: Biology and Pathogenesis Clinical Microbiology Reviews. 34 4 e00024–19 2021 10.1128/CMR.00024-19
- 2.Alday P.H., Bruzual I., Nilsen A., Pou S., Winter R., Ben Mamoun C., Riscoe M.K., Doggett J.S.: Genetic Evidence for Cytochrome b Qi Site Inhibition by 4(1H)-Quinolone-3-Diarylethers and Antimycin in Toxoplasma gondii. Antimicrob Agents Chemother. 61(2) e01866–16 (2017) doi:
10.1128/AAC.01866-16
AldayP.H. BruzualI. NilsenA. PouS. WinterR. Ben MamounC. RiscoeM.K. DoggettJ.S. Genetic Evidence for Cytochrome b Qi Site Inhibition by 4(1H)-Quinolone-3-Diarylethers and Antimycin in Toxoplasma gondii Antimicrob Agents Chemother 61 2 e01866–16 2017 10.1128/AAC.01866-16
- 3.Allain T., Amat C.B., Motta J.P., Manko A., Buret A.G.: Interactions of Giardia sp. with the intestinal barrier: Epithelium, mucus, and microbiota. Tissue Barriers. 5(1), e1274354 (2017) doi:
10.1080/21688370.2016.1274354
AllainT. AmatC.B. MottaJ.P. MankoA. BuretA.G. Interactions of Giardia sp. with the intestinal barrier: Epithelium, mucus, and microbiota Tissue Barriers. 5 1 e1274354 2017 10.1080/21688370.2016.1274354
- 4.Alshahethi M.A., Al-Hadheq A.A., Edrees W.H., Abdullah Q.Y., Al-Awar M.S.: Cutaneous leishmaniasis among attending hospitals and health centers in amran governorate, yemen. Electronic Journal of University of Aden for Basic and Applied Sciences. 5(3) 269–276 (2024) doi:
10.47372/ejua-ba.2024.3.373
AlshahethiM.A. Al-HadheqA.A. EdreesW.H. AbdullahQ.Y. Al-AwarM.S. Cutaneous leishmaniasis among attending hospitals and health centers in amran governorate, yemen Electronic Journal of University of Aden for Basic and Applied Sciences 5 3 269 276 2024 10.47372/ejua-ba.2024.3.373
- 5.Amelo W. and Makonnen E.: Efforts Made to Eliminate Drug-Resistant Malaria and Its Challenges. BioMed Research International. 2021(1), 5539544 (2021) doi:
10.1155/2021/5539544
AmeloW. MakonnenE. Efforts Made to Eliminate Drug-Resistant Malaria and Its Challenges BioMed Research International 2021 1 5539544 2021 10.1155/2021/5539544
- 6.Andriantsoanirina V., Khim N., Ratsimbasoa A., Witkowski B., Benedet C., Canier L., Bouchier C., Tichit M., Durand R., Ménard D.: Plasmodium falciparum Na+/H+ Exchanger (pfnhe-1) Genetic Polymorphism in Indian Ocean Malaria-Endemic Areas. The American Journal of Tropical Medicine and Hygiene. 88(1), 37 (2013) doi:
10.4269/ajtmh.2012.12-0359
AndriantsoanirinaV. KhimN. RatsimbasoaA. WitkowskiB. BenedetC. CanierL. BouchierC. TichitM. DurandR. MénardD. Plasmodium falciparum Na+/H+ Exchanger (pfnhe-1) Genetic Polymorphism in Indian Ocean Malaria-Endemic Areas The American Journal of Tropical Medicine and Hygiene 88 1 37 2013 10.4269/ajtmh.2012.12-0359
- 7.Ángeles-Arvizu A., Enriquez-Flores S., Jiménez-Gutiérrez A., Pérez-Rangel A., Luna-Arias J.P., Castillo-Romero A., Hernández J.M., León-Avila G.: MDR1 protein (ABC-C1) Over Expression in Giardia Intestinalis Incubated with Albendazole and Nitazoxanide. Acta Parasit. 66(4) 1158–1166 (2021) doi:
10.1007/s11686-021-00385-5
Ángeles-ArvizuA. Enriquez-FloresS. Jiménez-GutiérrezA. Pérez-RangelA. Luna-AriasJ.P. Castillo-RomeroA. HernándezJ.M. León-AvilaG. MDR1 protein (ABC-C1) Over Expression in Giardia Intestinalis Incubated with Albendazole and Nitazoxanide Acta Parasit 66 4 1158 1166 2021 10.1007/s11686-021-00385-5
- 8.Argüello-García R., Cruz-Soto M., González-Trejo R., Paz-Maldonado L.M.T., Bazán-Tejeda M.L., Mendoza-Hernández G., Ortega-Pierres G.: An antioxidant response is involved in resistance of Giardia duodenalis to albendazole. Front Microbiol. 6, 286 (2015) doi:
10.3389/fmicb.2015.00286
Argüello-GarcíaR. Cruz-SotoM. González-TrejoR. Paz-MaldonadoL.M.T. Bazán-TejedaM.L. Mendoza-HernándezG. Ortega-PierresG. An antioxidant response is involved in resistance of Giardia duodenalis to albendazole Front Microbiol 6 286 2015 10.3389/fmicb.2015.00286
- 9.Asare K.K., Africa J., Mbata J., Opoku Y.K.: The emergence of chloroquine-sensitive Plasmodium falciparum is influenced by selected communities in some parts of the Central Region of Ghana. Malar. J. 20(1) 447 (2021) doi:
10.1186/s12936-021-03985-8
AsareK.K. AfricaJ. MbataJ. OpokuY.K. The emergence of chloroquine-sensitive Plasmodium falciparum is influenced by selected communities in some parts of the Central Region of Ghana Malar. J 20 1 447 2021 10.1186/s12936-021-03985-8
- 10.Avcı K.D., Karakuş M., Kart Yaşar K.: Molecular survey of pfmdr-1, pfcrt, and pfk13 gene mutations among patients returning from Plasmodium falciparum endemic areas to Turkey. Malar J. 23(1) 286 (2024) doi:
10.1186/s12936-024-05107-6.
AvcıK.D. KarakuşM. Kart YaşarK. Molecular survey of pfmdr-1, pfcrt, and pfk13 gene mutations among patients returning from Plasmodium falciparum endemic areas to Turkey Malar J 23 1 286 2024 10.1186/s12936-024-05107-6
- 11.Babokhov P., Sanyaolu A.O., Oyibo W.A., Fagbenro-Beyioku A.F., Iriemenam N.C.: A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis. Pathogens and Global Health. 107(5) 242–252 (2013) doi:
10.1179/2047773213Y.0000000105
BabokhovP. SanyaoluA.O. OyiboW.A. Fagbenro-BeyiokuA.F. IriemenamN.C. A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis Pathogens and Global Health 107 5 242 252 2013 10.1179/2047773213Y.0000000105
- 12.Baina M.T., Djontu J.C., Mbama Ntabi J.D., Mfoutou Mapanguy C.C., Lissom A., Vouvoungui C.J., Boumpoutou R.K., Mouanga A.M., Nguimbi E., Ntoumi F.: Polymorphisms in the Pfcrt, Pfmdr1, and Pfk13 genes of Plasmodium falciparum isolates from southern Brazzaville, Republic of Congo. Sci Rep. 14(1), 27988 (2024) doi:
10.1038/s41598-024-78670-2
BainaM.T. DjontuJ.C. Mbama NtabiJ.D. Mfoutou MapanguyC.C. LissomA. VouvounguiC.J. BoumpoutouR.K. MouangaA.M. NguimbiE. NtoumiF. Polymorphisms in the Pfcrt, Pfmdr1, and Pfk13 genes of Plasmodium falciparum isolates from southern Brazzaville, Republic of Congo Sci Rep 14 1 27988 2024 10.1038/s41598-024-78670-2
- 13.Balaji S.N., Deshmukh R., Trivedi V.: Severe malaria: Biology, clinical manifestation, pathogenesis and consequences. Journal of Vector Borne Diseases. 57(1) 1 (2020) doi:
10.4103/0972-9062.308793
BalajiS.N. DeshmukhR. TrivediV. Severe malaria: Biology, clinical manifestation, pathogenesis and consequences Journal of Vector Borne Diseases 57 1 1 2020 10.4103/0972-9062.308793
- Berberian D.A.: Treatment and prophylaxis of malaria with aralen. J Palest Arab Med Assoc. 2(6) 143–151 (1947)
- 15.Bisetegn H., Zeleke A.J., Gadisa E., Shumie G., Damte D., Fenta T., Behaksra S., Bayih A.G.: Clinical, parasitological and molecular profiles of Cutaneous Leishmaniasis and its associated factors among clinically suspected patients attending Borumeda Hospital, North-East Ethiopia. PLoS Negl Trop Dis. 14(8) e0008507 (2020) doi:
10.1371/journal.pntd.0008507
BisetegnH. ZelekeA.J. GadisaE. ShumieG. DamteD. FentaT. BehaksraS. BayihA.G. Clinical, parasitological and molecular profiles of Cutaneous Leishmaniasis and its associated factors among clinically suspected patients attending Borumeda Hospital, North-East Ethiopia PLoS Negl Trop Dis 14 8 e0008507 2020 10.1371/journal.pntd.0008507
- 16.Black M.W. and Boothroyd J.C.: Lytic Cycle of Toxoplasma gondii. Microbiol Mol Biol Rev. 64(3) 607–623 (2000) doi:
10.1128/MMBR.64.3.607-623.2000
BlackM.W. BoothroydJ.C. Lytic Cycle of Toxoplasma gondii Microbiol Mol Biol Rev. 64 3 607 623 2000 10.1128/MMBR.64.3.607-623.2000
- Bogacz J.: 1954. [Comparative effect of various synthetic agents and various antibiotics, including spiramycin, on Toxoplasma]. Bull Soc Pathol Exot Filiales. 47(6) 903–915
- 18.Bouteille B., Oukem O., Bisser S., Dumas M.: Treatment perspectives for human African trypanosomiasis. Fundamental & Clinical Pharmacology. 17(2) 171–181 (2003) doi:
10.1046/j.1472-8206.2003.00167.x
BouteilleB. OukemO. BisserS. DumasM. Treatment perspectives for human African trypanosomiasis Fundamental & Clinical Pharmacology 17 2 171 181 2003 10.1046/j.1472-8206.2003.00167.x
- 19.Bridges D.J., Gould M.K., Nerima B., Mäser P., Burchmore R.J.S., Koning H.P.: Loss of the High-Affinity Pentamidine Transporter Is Responsible for High Levels of Cross-Resistance between Arsenical and Diamidine Drugs in African Trypanosomes. Mol Pharmacol. 71(4) 1098–1108 (2007) doi:
10.1124/mol.106.031351
BridgesD.J. GouldM.K. NerimaB. MäserP. BurchmoreR.J.S. KoningH.P. Loss of the High-Affinity Pentamidine Transporter Is Responsible for High Levels of Cross-Resistance between Arsenical and Diamidine Drugs in African Trypanosomes Mol Pharmacol. 71 4 1098 1108 2007 10.1124/mol.106.031351
- 20.Büscher P., Cecchi G., Jamonneau V., Priotto G.: Human African trypanosomiasis. Lancet. 390(10110) 2397–2409 (2017) doi:
10.1016/S0140-6736(17)31510-6
BüscherP. CecchiG. JamonneauV. PriottoG. Human African trypanosomiasis Lancet. 390 10110 2397 2409 2017 10.1016/S0140-6736(17)31510-6
- 21.Camuset G., Remy V., Hansmann Y., Christmann D., Gomes de Albuquerque C., Sena Casseb G.A.: [Mucocutaneous leishmaniasis in Brazilian Amazonia]. Med Mal Infect. 37(6) 343–346 (2007) doi:
10.1016/j.medmal.2007.03.012.
CamusetG. RemyV. HansmannY. ChristmannD. Gomes de AlbuquerqueC. Sena CassebG.A. [Mucocutaneous leishmaniasis in Brazilian Amazonia] Med Mal Infect. 37 6 343 346 2007 10.1016/j.medmal.2007.03.012
- 22.Carnielli J.B.T., Monti-Rocha R., Costa D.L., Molina Sesana A., Pansini L.N.N., Segatto M., Mottram J.C., Costa C.H.N., Carvalho S.F.G., Dietze R.: Natural Resistance of Leishmania infantum to miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil. Am J Trop Med Hyg. 101(4) 789–794 (2019) doi:
10.4269/ajtmh.18-0949
CarnielliJ.B.T. Monti-RochaR. CostaD.L. Molina SesanaA. PansiniL.N.N. SegattoM. MottramJ.C. CostaC.H.N. CarvalhoS.F.G. DietzeR. Natural Resistance of Leishmania infantum to miltefosine Contributes to the Low Efficacy in the Treatment of Visceral Leishmaniasis in Brazil Am J Trop Med Hyg. 101 4 789 794 2019 10.4269/ajtmh.18-0949
- CDC. 2019. CDC – DPDx – Amebiasis.
https://www.cdc.gov/dpdx/amebiasis/index.html. [accessed 2024 Aug 27] - CDC. 2024a. CDC – DPDx – Malaria.
https://www.cdc.gov/dpdx/malaria/index.html. [accessed 2024 Aug 26] - CDC. 2024b. Appendix A: Malaria in the United States: Treatment Tables. Malaria.
https://www.cdc.gov/malaria/hcp/clinical-guidance/malaria-treatment-tables.html. [accessed 2024 Sep 7] - CDC. 2024c. About Toxoplasmosis. Toxoplasmosis.
https://www.cdc.gov/toxoplasmosis/about/index.html. [accessed 2024 Sep 15] - CDC. 2024d. Clinical Care of Human African Trypanosomiasis. Sleeping Sickness (African Trypanosomiasis).
https://www.cdc.gov/sleeping-sickness/hcp/clinical-care/index.html [accessed 2024 Sep 9] - CDC. 2024e. Patient Care for Giardia Infection. Giardia.
https://www.cdc.gov/giardia/hcp/clinical-care/index.html. [accessed 2024 Sep 15] - 29.Cernikova L., Faso C., Hehl A.B.: Five facts about Giardia lamblia. PLOS Pathogens. 14(9) e1007250 (2018) doi:
10.1371/journal.ppat.1007250
CernikovaL. FasoC. HehlA.B. Five facts about Giardia lamblia PLOS Pathogens 14 9 e1007250 2018 10.1371/journal.ppat.1007250
- 30.Certad G., Viscogliosi E., Chabé M., Cacciò S.M.: Pathogenic Mechanisms of Cryptosporidium and Giardia. Trends in Parasitology. 33(7) 561–576 (2017) doi:
10.1016/j.pt.2017.02.006
CertadG. ViscogliosiE. ChabéM. CacciòS.M. Pathogenic Mechanisms of Cryptosporidium and Giardia Trends in Parasitology. 33 7 561 576 2017 10.1016/j.pt.2017.02.006
- 31.Ciuca L., Pepe P., Bosco A., Caccio S.M., Maurelli M.P., Sannella A.R., Vismarra A., Cringoli G., Kramer L., Rinaldi L., et al. Effectiveness of Fenbendazole and Metronidazole Against Giardia Infection in Dogs Monitored for 50-Days in Home-Conditions. Front Vet Sci. 8 626424 (2021) doi:
10.3389/fvets.2021.626424
CiucaL. PepeP. BoscoA. CaccioS.M. MaurelliM.P. SannellaA.R. VismarraA. CringoliG. KramerL. RinaldiL. Effectiveness of Fenbendazole and Metronidazole Against Giardia Infection in Dogs Monitored for 50-Days in Home-Conditions Front Vet Sci 8 626424 2021 10.3389/fvets.2021.626424
- 32.Cowell A.N., Winzeler E.A.: The genomic architecture of anti-malarial drug resistance. Brief Funct Genomics. 18(5) 314–328 (2019) doi:
10.1093/bfgp/elz008
CowellA.N. WinzelerE.A. The genomic architecture of anti-malarial drug resistance Brief Funct Genomics. 18 5 314 328 2019 10.1093/bfgp/elz008
- 33.Cui Z., Li J., Chen Y., Zhang L.: Molecular epidemiology, evolution, and phylogeny of Entamoeba spp. Infection, Genetics and Evolution. 75, 104018 (2019) doi:
10.1016/j.meegid.2019.104018
CuiZ. LiJ. ChenY. ZhangL. Molecular epidemiology, evolution, and phylogeny of Entamoeba spp Infection, Genetics and Evolution 75 104018 2019 10.1016/j.meegid.2019.104018
- 34.Dama S., Diakite B., Dinkorma O.T., Niangaly A., Kone A.K., Dara A., Kone A., Bamadio A., Kodio A., Doumbia D., et al.: Dynamics of Pfcrt K76T and Pfmdr1N86Y fifteen years after the withdrawal of chloroquine in Mali. AJPME. 2(1), 0–0 (2024) doi:
10.35995/ajpme2010004
DamaS. DiakiteB. DinkormaO.T. NiangalyA. KoneA.K. DaraA. KoneA. BamadioA. KodioA. DoumbiaD. Dynamics of Pfcrt K76T and Pfmdr1N86Y fifteen years after the withdrawal of chloroquine in Mali AJPME 2 1 0 0 2024 10.35995/ajpme2010004
- 35.Doliwa C., Escotte-Binet S., Aubert D., Sauvage V., Velard F., Schmid A., Villena I.: Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters. Parasite. 20, 19 (2013) doi:
10.1051/parasite/2013020
DoliwaC. Escotte-BinetS. AubertD. SauvageV. VelardF. SchmidA. VillenaI. Sulfadiazine resistance in Toxoplasma gondii: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters Parasite 20 19 2013 10.1051/parasite/2013020
- Dubey J.P.: Toxoplasmosis of Animals and Humans. 3rd ed. Boca Raton: CRC Press. (2021)
- 37.Dubey J.P. and Jones J.L.: Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 38(11) 1257–1278 (2008) doi:
10.1016/j.ijpara.2008.03.007
DubeyJ.P. JonesJ.L. Toxoplasma gondii infection in humans and animals in the United States Int J Parasitol. 38 11 1257 1278 2008 10.1016/j.ijpara.2008.03.007
- 38.Dunay I.R., Gajurel K., Dhakal R., Liesenfeld O., Montoya J.G.: Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice. Clin Microbiol Rev. 31(4), e00057–17 (2018) doi:
10.1128/CMR.00057-17
DunayI.R. GajurelK. DhakalR. LiesenfeldO. MontoyaJ.G. Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice Clin Microbiol Rev. 31 4 e00057–17 2018 10.1128/CMR.00057-17
- 39.Faucher B., Pomares C., Fourcade S., Benyamine A., Marty P., Pratlong L., Faraut F., Mary C., Piarroux R., Dedet J.P., et al.: Mucosal Leishmania infantum leishmaniasis: specific pattern in a multicentre survey and historical cases. J Infect. 63(1), 76–82 (2011) doi:
10.1016/j.jinf.2011.03.012
FaucherB. PomaresC. FourcadeS. BenyamineA. MartyP. PratlongL. FarautF. MaryC. PiarrouxR. DedetJ.P. Mucosal Leishmania infantum leishmaniasis: specific pattern in a multicentre survey and historical cases J Infect 63 1 76 82 2011 10.1016/j.jinf.2011.03.012
- 40.Reed D.A., Nomura T., Talley A.K., Cooper R.A., Dzekunov S.M., Ferdig M.T., Ursos L.M., Sidhu A.B., Naudé B., Deitsch K.W., et al.: Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 6(4), 861–871 (2000) doi:
10.1016/s1097-2765(05)00077-8
ReedD.A. NomuraT. TalleyA.K. CooperR.A. DzekunovS.M. FerdigM.T. UrsosL.M. SidhuA.B. NaudéB. DeitschK.W. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance Mol Cell 6 4 861 871 2000 10.1016/s1097-2765(05)00077-8
- 41.Franco J.R., Priotto G., Paone M., Cecchi G., Ebeja A.K., Simarro P.P., Sankara D., Metwally S.B.A., Argaw D.D.: The elimination of human African trypanosomiasis: Monitoring progress towards the 2021–2030 WHO road map targets. PLOS Neglected Tropical Diseases 18(4), e0012111 (2024) doi:
10.1371/journal.pntd.0012111
FrancoJ.R. PriottoG. PaoneM. CecchiG. EbejaA.K. SimarroP.P. SankaraD. MetwallyS.B.A. ArgawD.D. The elimination of human African trypanosomiasis: Monitoring progress towards the 2021–2030 WHO road map targets PLOS Neglected Tropical Diseases 18 4 e0012111 2024 10.1371/journal.pntd.0012111
- 42.Gelaw Y.M., Dagnew G.W., Alene G.D., Gangneux J.P., Robert-Gangneux F.: Toxoplasma gondii seroprevalence among pregnant women in Africa: A systematic review and meta-analysis. PLOS Neglected Tropical Diseases. 18(5), e0012198 (2024) doi:
10.1371/journal.pntd.0012198
GelawY.M. DagnewG.W. AleneG.D. GangneuxJ.P. Robert-GangneuxF. Toxoplasma gondii seroprevalence among pregnant women in Africa: A systematic review and meta-analysis PLOS Neglected Tropical Diseases. 18 5 e0012198 2024 10.1371/journal.pntd.0012198
- 43.Ghosal A., Sardar S.K., Haldar T., Maruf M., Saito-Nakano Y., Dutta S., Nozaki T., Ganguly S.: Genotyping and epidemiological distribution of diarrhea-causing isolates of Giardia duodenalis in southeastern part of West Bengal, India. Parasitol Res. 122(11), 2567–2584 (2023) doi:
10.1007/s00436-023-07956-7.44
GhosalA. SardarS.K. HaldarT. MarufM. Saito-NakanoY. DuttaS. NozakiT. GangulyS. Genotyping and epidemiological distribution of diarrhea-causing isolates of Giardia duodenalis in southeastern part of West Bengal, India Parasitol Res 122 11 2567 2584 2023 10.1007/s00436-023-07956-7.44
- 44.Gibb H., Devleesschauwer B., Bolger P.M., Wu F., Ezendam J., Cliff J., Zeilmaker M., Verger P., Pitt J., Baines J., et al. World Health Organization estimates of the global and regional disease burden of four foodborne chemical toxins, 2010: a data synthesis. F1000Res. 4, 1393 (2015) doi:
10.12688/f1000research.7340.1
GibbH. DevleesschauwerB. BolgerP.M. WuF. EzendamJ. CliffJ. ZeilmakerM. VergerP. PittJ. BainesJ. World Health Organization estimates of the global and regional disease burden of four foodborne chemical toxins, 2010: a data synthesis F1000Res 4 1393 2015 10.12688/f1000research.7340.1
- 45.Gil J.P. and Fançony C.: Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs). Front Pharmacol. 12 (2021) doi:
10.3389/fphar.2021.759422 [accessed 2024 Aug 31]
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.759422/full GilJ.P. FançonyC. Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs) Front Pharmacol 12 2021 10.3389/fphar.2021.759422 [accessed 2024 Aug 31]https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.759422/full - Keating G.M.: Fosfomycin trometamol: A review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria. Drugs. 73, 1951–1966 (2013)
https://doi.org/10.1007/s40265-013-0143-y - 47.Graf F.E., Ludin P., Wenzler T., Kaiser M., Brun R., Pyana P.P., Büscher P., Koning H.P. de, Horn D., Mäser P.: Aquaporin 2 Mutations in Trypanosoma brucei gambiense Field Isolates Correlate with Decreased Susceptibility to Pentamidine and Melarsoprol. PLOS Neglected Tropical Diseases. 7(10), e2475 (2013) doi:
10.1371/journal.pntd.0002475
GrafF.E. LudinP. WenzlerT. KaiserM. BrunR. PyanaP.P. BüscherP. KoningH.P. de HornD. MäserP. Aquaporin 2 Mutations in Trypanosoma brucei gambiense Field Isolates Correlate with Decreased Susceptibility to Pentamidine and Melarsoprol PLOS Neglected Tropical Diseases. 7 10 e2475 2013 10.1371/journal.pntd.0002475
- 48.Guimaraes J.L., Lourie E.M.: The inhibition of some pharmacological actions of pentamidine by suramin. British Journal of Pharmacology and Chemotherapy. 6(3), 514 (1951) doi:
10.1111/j.1476-5381.1951.tb00663.x
GuimaraesJ.L. LourieE.M. The inhibition of some pharmacological actions of pentamidine by suramin British Journal of Pharmacology and Chemotherapy 6 3 514 1951 10.1111/j.1476-5381.1951.tb00663.x
- 49.Gupta P., Singh K., Balodhi A., Jain K., Deeba F., Salam N.: Prevalence of Amoebiasis and Associated Complications in India: A Systematic Review. Acta Parasitologica. 67 (2022) doi:
10.1007/s11686-022-00547-z.
GuptaP. SinghK. BalodhiA. JainK. DeebaF. SalamN. Prevalence of Amoebiasis and Associated Complications in India: A Systematic Review Acta Parasitologica 67 2022 10.1007/s11686-022-00547-z
- 50.Hajj R.E., Tawk L., Itani S., Hamie M., Ezzeddine J., El Sabban M., El Hajj H.: Toxoplasmosis: Current and Emerging Parasite Druggable Targets. Microorganisms. 9(12), 2531 (2021) doi:
10.3390/microorganisms9122531
HajjR.E. TawkL. ItaniS. HamieM. EzzeddineJ. El SabbanM. El HajjH. Toxoplasmosis: Current and Emerging Parasite Druggable Targets Microorganisms 9 12 2531 2021 10.3390/microorganisms9122531
- 51.Hammershaimb E.A. and Berry A.A.: Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond. Expert Review of Vaccines. 23(1), 49–52 (2024) doi:
10.1080/14760584.2023.2292204
HammershaimbE.A. BerryA.A. Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond Expert Review of Vaccines 23 1 49 52 2024 10.1080/14760584.2023.2292204
- 52.Hassen J., Alemayehu G.S., Dinka H., Golassa L.: High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia. Malaria Journal. 21(1), 286 (2022) doi:
10.1186/s12936-022-04304-5
HassenJ. AlemayehuG.S. DinkaH. GolassaL. High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia Malaria Journal 21 1 286 2022 10.1186/s12936-022-04304-5
- 53.Herwaldt B.L., Berman J.D.: Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg. 46(3), 296–306 (1992) doi:
10.4269/ajtmh.1992.46.296
HerwaldtB.L. BermanJ.D. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies Am J Trop Med Hyg 46 3 296 306 1992 10.4269/ajtmh.1992.46.296
- 54.Hung D.T., Tran L., Tam D.N.H., Elshafei G., Cuong N.T.K., Ha N.X., Khader S.A.E., Le Quang L., Shaikhkhalil H.W., Abdallfatah A., et al.: The prevalence of Pfk13 polymorphism in malaria patients treated with artemisinin-based therapy: a systematic review and meta-analysis. Parasitol Res. 123(5), 209 (2024) doi:
10.1007/s00436-024-08203-3
HungD.T. TranL. TamD.N.H. ElshafeiG. CuongN.T.K. HaN.X. KhaderS.A.E. Le QuangL. ShaikhkhalilH.W. AbdallfatahA. The prevalence of Pfk13 polymorphism in malaria patients treated with artemisinin-based therapy: a systematic review and meta-analysis Parasitol Res 123 5 209 2024 10.1007/s00436-024-08203-3
- 55.Imwong M., Pukrittakayamee S., Looareesuwan S., Pasvol G., Poirreiz J., White N.J., Snounou G.: Association of Genetic Mutations in Plasmodium vivax dhfr with Resistance to Sulfadoxine-Pyrimethamine: Geographical and Clinical Correlates. Anti microbial Agents and Chemotherapy. 45(11), 3122–3127 (2001) doi:
10.1128/aac.45.11.3122-3127.2001
ImwongM. PukrittakayameeS. LooareesuwanS. PasvolG. PoirreizJ. WhiteN.J. SnounouG. Association of Genetic Mutations in Plasmodium vivax dhfr with Resistance to Sulfadoxine-Pyrimethamine: Geographical and Clinical Correlates Anti microbial Agents and Chemotherapy 45 11 3122 3127 2001 10.1128/aac.45.11.3122-3127.2001
- 56.Issa I., Lamine M.M., Hubert V., Ilagouma A., Adehossi E., Mahamadou A., Lobo N.F., Sarr D., Shollenberger L.M., Sandrine H., et al. Prevalence of Mutations in the Pfdhfr, Pfdhps, and Pfmdr1 Genes of Malarial Parasites Isolated from Symptomatic Patients in Dogondoutchi, Niger. Tropical Medicine and Infectious Disease. 7(8), 155 (2022) doi:
10.3390/tropicalmed7080155
IssaI. LamineM.M. HubertV. IlagoumaA. AdehossiE. MahamadouA. LoboN.F. SarrD. ShollenbergerL.M. SandrineH. Prevalence of Mutations in the Pfdhfr, Pfdhps, and Pfmdr1 Genes of Malarial Parasites Isolated from Symptomatic Patients in Dogondoutchi, Niger Tropical Medicine and Infectious Disease 7 8 155 2022 10.3390/tropicalmed7080155
- 57.Jackson D., Salem A., Coombs G.H.: The invitro activity of metronidazole against strains of Escherichia coli with impaired DNA repair systems. Journal of Antimicrobial Chemotherapy. 13(3), 227–236 (1984) doi:
10.1093/jac/13.3.227
JacksonD. SalemA. CoombsG.H. The invitro activity of metronidazole against strains of Escherichia coli with impaired DNA repair systems Journal of Antimicrobial Chemotherapy 13 3 227 236 1984 10.1093/jac/13.3.227
- Johnson A.M.: Toxoplasma: Biology, Pathology, Immunology, and Treatment. In: Coccidiosis of Man and Domestic Animals. CRC Press. 34 p. (1990)
- 59.Jones J.L., Kruszon-Moran D., Elder S., Rivera H.N., Press C., Montoya J.G., McQuillan G.M.: Toxoplasma gondii Infection in the United States. Am J Trop Med Hyg. 98(2), 551–557 (2018) doi:
10.4269/ajtmh.17-0677
JonesJ.L. Kruszon-MoranD. ElderS. RiveraH.N. PressC. MontoyaJ.G. McQuillanG.M. Toxoplasma gondii Infection in the United States Am J Trop Med Hyg 98 2 551 557 2018 10.4269/ajtmh.17-0677
- 60.Kalavani S, Matin S., Rahmanian V., Meshkin A., Bahadori Mazidi B., Taghipour A., Abdoli A.: Prevalence of Giardia duodenalis among African children: A systematic review and meta-analysis. Parasite Epidemiology and Control. 26, e00365 (2024) doi:
10.1016/j.parepi.2024.e00365
KalavaniS MatinS. RahmanianV. MeshkinA. Bahadori MazidiB. TaghipourA. AbdoliA. Prevalence of Giardia duodenalis among African children: A systematic review and meta-analysis Parasite Epidemiology and Control 26 e00365 2024 10.1016/j.parepi.2024.e00365
- 61.Kaplan B., Kahn L.H., Monath T.P., Woodall J.: “ONE HEALTH” and parasitology. Parasites & Vectors. 2(1), 36 (2009) doi:
10.1186/1756-3305-2-36
KaplanB. KahnL.H. MonathT.P. WoodallJ. “ONE HEALTH” and parasitology Parasites & Vectors 2 1 36 2009 10.1186/1756-3305-2-36
- 62.Koné M., Kaba D., Kaboré J., Thomas L.F., Falzon L.C., Koffi M., Kouamé C.M., Ahouty B., Compaoré C.F.A., N’Gouan E.K., et al.: Passive surveillance of human African trypanosomiasis in Côte d’Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics. PLOS Neglected Tropical Diseases. 15(8) e0009656 (2021) doi:
10.1371/journal.pntd.0009656
KonéM. KabaD. KaboréJ. ThomasL.F. FalzonL.C. KoffiM. KouaméC.M. AhoutyB. CompaoréC.F.A. N’GouanE.K. Passive surveillance of human African trypanosomiasis in Côte d’Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics PLOS Neglected Tropical Diseases 15 8 e0009656 2021 10.1371/journal.pntd.0009656
- 63.de Koning H.P., Anderson L.F., Stewart M., Burchmore R.J.S., Wallace L.J.M., Barrett M.P.: The Trypanocide Diminazene Aceturate Is Accumulated Predominantly through the TbAT1 Purine Transporter: Additional Insights on Diamidine Resistance in African Trypanosomes. Antimicrobial Agents and Chemotherapy. 48(5), 1515–1519 (2004) doi:
10.1128/aac.48.5.1515-1519.2004
de KoningH.P. AndersonL.F. StewartM. BurchmoreR.J.S. WallaceL.J.M. BarrettM.P. The Trypanocide Diminazene Aceturate Is Accumulated Predominantly through the TbAT1 Purine Transporter: Additional Insights on Diamidine Resistance in African Trypanosomes Antimicrobial Agents and Chemotherapy 48 5 1515 1519 2004 10.1128/aac.48.5.1515-1519.2004
- Konstantinovic N, Guegan H, Stäjner T, Belaz S, Robert-Gangneux F. 2019. Treatment of toxoplasmosis: Current options and future perspectives. Food and Waterborne Parasitology. 15:e00036. doi:10.1016/j.fawpar.2019.e00036.
- 65.Krakovka S., Ribacke U., Miyamoto Y., Eckmann L., Svärd S.: Characterization of Metronidazole-Resistant Giardia intestinalis Lines by Comparative Transcriptomics and Proteomics. Front Microbiol. 13 (2022) doi:
10.3389/fmicb.2022.834008 [accessed 2024 Aug 27]
https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2022.834008/full KrakovkaS. RibackeU. MiyamotoY. EckmannL. SvärdS. Characterization of Metronidazole-Resistant Giardia intestinalis Lines by Comparative Transcriptomics and Proteomics Front Microbiol 13 2022 10.3389/fmicb.2022.834008 [accessed 2024 Aug 27]https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2022.834008/full - 66.Lagunas-Rangel F.A., Yee J., Bermúdez-Cruz R.M.: An update on cell division of Giardia duodenalis trophozoites. Microbiological Research. 250, 126807 (2021) doi:
10.1016/j.micres.2021.126807
Lagunas-RangelF.A. YeeJ. Bermúdez-CruzR.M. An update on cell division of Giardia duodenalis trophozoites Microbiological Research 250 126807 2021 10.1016/j.micres.2021.126807
- 67.Lapinskas P.J. and Ben-Harari R.R.: Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis. Postgraduate Medicine. 131(8), 589–596 (2019) doi:
10.1080/00325481.2019.1655258
LapinskasP.J. Ben-HarariR.R. Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis Postgraduate Medicine 131 8 589 596 2019 10.1080/00325481.2019.1655258
- 68.Makarov A., Began J., Mautone I.C., Pinto E., Ferguson L., Zoltner M., Zoll S., Field M.C.: The role of invariant surface glycoprotein 75 in xenobiotic acquisition by African trypanosomes. Microb Cell. 10(2), 18–35 (2023) doi:
10.15698/mic2023.02.790
MakarovA. BeganJ. MautoneI.C. PintoE. FergusonL. ZoltnerM. ZollS. FieldM.C. The role of invariant surface glycoprotein 75 in xenobiotic acquisition by African trypanosomes Microb Cell 10 2 18 35 2023 10.15698/mic2023.02.790
- 69.Mann S., Frasca K., Scherrer S., Henao-Martínez A.F., Newman S., Ramanan P., Suarez J.A.: A Review of Leishmaniasis: Current Knowledge and Future Directions. Curr Trop Med Rep. 8(2), 121–132 (2021) doi:
10.1007/s40475-021-00232-7
MannS. FrascaK. ScherrerS. Henao-MartínezA.F. NewmanS. RamananP. SuarezJ.A. A Review of Leishmaniasis: Current Knowledge and Future Directions Curr Trop Med Rep 8 2 121 132 2021 10.1007/s40475-021-00232-7
- 70.Marques M.M., Costa M.R.F., Santana Filho F.S., Vieira J.L.F., Nascimento M.T.S., Brasil L.W., Nogueira F., Silveira H., Reyes-Lecca R.C., Monteiro W.M., et al.: Plasmodium vivax Chloroquine Resistance and Anemia in the Western Brazilian Amazon. Antimicrobial Agents and Chemotherapy. 58(1), 342–347 (2014) doi:
10.1128/aac.02279-12
MarquesM.M. CostaM.R.F. Santana FilhoF.S. VieiraJ.L.F. NascimentoM.T.S. BrasilL.W. NogueiraF. SilveiraH. Reyes-LeccaR.C. MonteiroW.M. Plasmodium vivax Chloroquine Resistance and Anemia in the Western Brazilian Amazon Antimicrobial Agents and Chemotherapy 58 1 342 347 2014 10.1128/aac.02279-12
- 71.Matovu E., Stewart M.L., Geiser F., Brun R., Mäser P., Wallace L.J.M., Burchmore R.J., Enyaru J.C.K., Barrett M.P., Kaminsky R., et al.: Mechanisms of Arsenical and Diamidine Uptake and Resistance in Trypanosoma brucei. Eukaryotic Cell. 2(5), 1003–1008 (2003) doi:
10.1128/ec.2.5.1003-1008.2003
MatovuE. StewartM.L. GeiserF. BrunR. MäserP. WallaceL.J.M. BurchmoreR.J. EnyaruJ.C.K. BarrettM.P. KaminskyR. Mechanisms of Arsenical and Diamidine Uptake and Resistance in Trypanosoma brucei Eukaryotic Cell 2 5 1003 1008 2003 10.1128/ec.2.5.1003-1008.2003
- 72.McFadden D.C., Tomavo S., Berry E.A., Boothroyd J.C.: Characterization of cytochrome b from Toxoplasma gondii and Qo domain mutations as a mechanism of atovaquone-resistance. Molecular and Biochemical Parasitology. 108(1), 1–12 (2000) doi:
10.1016/S0166-6851(00)00184-5
McFaddenD.C. TomavoS. BerryE.A. BoothroydJ.C. Characterization of cytochrome b from Toxoplasma gondii and Qo domain mutations as a mechanism of atovaquone-resistance Molecular and Biochemical Parasitology 108 1 1 12 2000 10.1016/S0166-6851(00)00184-5
- 73.Meneceur P., Bouldouyre M.A., Aubert D., Villena I., Menotti J., Sauvage V., Garin J.F., Derouin F.: In Vitro Susceptibility of Various Genotypic Strains of Toxoplasma gondii to Pyrimethamine, Sulfadiazine, and Atovaquone. Antimicrob Agents Chemother. 52(4), 1269–1277 (2008) doi:
10.1128/AAC.01203-07
MeneceurP. BouldouyreM.A. AubertD. VillenaI. MenottiJ. SauvageV. GarinJ.F. DerouinF. In Vitro Susceptibility of Various Genotypic Strains of Toxoplasma gondii to Pyrimethamine, Sulfadiazine, and Atovaquone Antimicrob Agents Chemother 52 4 1269 1277 2008 10.1128/AAC.01203-07
- Meshnick S.R. and Dobson M.J.: The History of Antimalarial Drugs. In: Rosenthal PJ, editor. Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery. Totowa, NJ: Humana Press. p. 15–25 (2001) [accessed 2024 Sep 7]
https://doi.org/10.1007/978-1-59259-111-4_2 - 75.Minbaeva G., Schweiger A., Bodosheva A., Kuttubaev O., Hehl A.B., Tanner I., Ziadinov I., Torgerson P.R., Deplazes P.: Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis. PLoS Negl Trop Dis. 7(2), e2043 (2013) doi:
10.1371/journal.pntd.0002043
MinbaevaG. SchweigerA. BodoshevaA. KuttubaevO. HehlA.B. TannerI. ZiadinovI. TorgersonP.R. DeplazesP. Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis PLoS Negl Trop Dis. 7 2 e2043 2013 10.1371/journal.pntd.0002043
- 76.Monis P.T., Caccio S.M., Thompson R.C.A.: Variation in Giardia: towards a taxonomic revision of the genus. Trends in Parasitology. 25(2), 93–100 (2009) doi:
10.1016/j.pt.2008.11.006
MonisP.T. CaccioS.M. ThompsonR.C.A. Variation in Giardia: towards a taxonomic revision of the genus Trends in Parasitology 25 2 93 100 2009 10.1016/j.pt.2008.11.006
- Moreira E.T. de S., Castro Faria Neto H.C. de, Reis P.A.: Chapter 17 – Cerebral malaria: Understanding the parasite pathogenesis in the brain. In: De Quevedo JL, Barichello T, Hasbun R, Dal-Pizzol F, editors. Neurobiology of Infectious Diseases. Academic Press. (Neurobiology of Disease). p. 291–304 (2025)
- 78.Moss S., Mańko E., Krishna S., Campino S., Clark T.G., Last A.: How has mass drug administration with dihydroartemisininpiperaquine impacted molecular markers of drug resistance? A systematic review. Malar J. 21(1), 186 (2022) doi:
10.1186/s12936-022-04181-y
MossS. MańkoE. KrishnaS. CampinoS. ClarkT.G. LastA. How has mass drug administration with dihydroartemisininpiperaquine impacted molecular markers of drug resistance? A systematic review Malar J 21 1 186 2022 10.1186/s12936-022-04181-y
- 79.Mukherjee A., Padmanabhan P.K., Singh S., Roy G., Girard I., Chatterjee M., Ouellette M., Madhubala R.: Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. Journal of Antimicrobial Chemotherapy. 59(2), 204–211 (2007) doi:
10.1093/jac/dkl494
MukherjeeA. PadmanabhanP.K. SinghS. RoyG. GirardI. ChatterjeeM. OuelletteM. MadhubalaR. Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani Journal of Antimicrobial Chemotherapy 59 2 204 211 2007 10.1093/jac/dkl494
- 80.Munday J.C., Eze A.A., Baker N., Glover L., Clucas C., Aguinaga Andrés D., Natto M.J., Teka I.A., McDonald J., Lee R.S., et al. Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs. Journal of Antimicrobial Chemotherapy. 69(3), 651–663 (2014) doi:
10.1093/jac/dkt442
MundayJ.C. EzeA.A. BakerN. GloverL. ClucasC. Aguinaga AndrésD. NattoM.J. TekaI.A. McDonaldJ. LeeR.S. Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs Journal of Antimicrobial Chemotherapy 69 3 651 663 2014 10.1093/jac/dkt442
- 81.Munday J.C., Settimo L., de Koning H.P.: Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei. Front Pharmacol. 6 (2015) doi:
10.3389/fphar.2015.00032
MundayJ.C. SettimoL. de KoningH.P. Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei Front Pharmacol 6 2015 10.3389/fphar.2015.00032
- 82.Naghavi M., Mestrovic T., Gray A., Hayoon A.G., Swetschinski L.R., Aguilar G.R., Weaver N.D., Ikuta K.S., Chung E., Wool E.E., et al.: Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Infectious Diseases. 24(8), 868–895 (2024) doi:
10.1016/S1473-3099(24)00158-0
NaghaviM. MestrovicT. GrayA. HayoonA.G. SwetschinskiL.R. AguilarG.R. WeaverN.D. IkutaK.S. ChungE. WoolE.E. Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 The Lancet Infectious Diseases 24 8 868 895 2024 10.1016/S1473-3099(24)00158-0
- 83.Nok A.J.: Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis. Parasitol Res. 90(1), 71–79 (2003) doi:
10.1007/s00436-002-0799-9
NokA.J. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis Parasitol Res 90 1 71 79 2003 10.1007/s00436-002-0799-9
- 84.Noronha M., Pawar V., Prajapati A., Subramanian R.B.: A literature review on traditional herbal medicines for malaria. South African Journal of Botany. 128 292–303 (2020) doi:
10.1016/j.sajb.2019.11.017
NoronhaM. PawarV. PrajapatiA. SubramanianR.B. A literature review on traditional herbal medicines for malaria South African Journal of Botany 128 292 303 2020 10.1016/j.sajb.2019.11.017
- 85.Nsobya S.L., Dokomajilar C., Joloba M., Dorsey G., Rosenthal P.J.: Resistance-Mediating Plasmodium falciparum pfcrt and pfmdr1 Alleles after Treatment with Artesunate-Amodiaquine in Uganda. Antimicrobial Agents and Chemotherapy. 51(8), 3023–3025 (2007) doi:
10.1128/aac.00012-07
NsobyaS.L. DokomajilarC. JolobaM. DorseyG. RosenthalP.J. Resistance-Mediating Plasmodium falciparum pfcrt and pfmdr1 Alleles after Treatment with Artesunate-Amodiaquine in Uganda Antimicrobial Agents and Chemotherapy 51 8 3023 3025 2007 10.1128/aac.00012-07
- 86.O’Neill P.M., Barton V.E., Ward S.A.: The molecular mechanism of action of artemisinin-the debate continues. Molecules. 15(3), 1705–1721 (2010) doi:
10.3390/molecules15031705
O’NeillP.M. BartonV.E. WardS.A. The molecular mechanism of action of artemisinin-the debate continues Molecules 15 3 1705 1721 2010 10.3390/molecules15031705
- 87.Pacheco M.A., Schneider K.A., Cheng Q., Munde E.O., Ndege C., Onyango C., Raballah E., Anyona S.B., Ouma C., Perkins D.J., et al. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H. Malar J. 19(1), 378 (2020) doi:
10.1186/s12936-020-03454-8
PachecoM.A. SchneiderK.A. ChengQ. MundeE.O. NdegeC. OnyangoC. RaballahE. AnyonaS.B. OumaC. PerkinsD.J. Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H Malar J 19 1 378 2020 10.1186/s12936-020-03454-8
- 88.Patel P., Bharti P.K., Bansal D., Ali N.A., Raman R.K., Mohapatra P.K., Sehgal R., Mahanta J., Sultan A.A., Singh N.: Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: A malaria elimination point of view. Sci Rep. 7(1), 16690 (2017) doi:
10.1038/s41598-017-16866-5
PatelP. BhartiP.K. BansalD. AliN.A. RamanR.K. MohapatraP.K. SehgalR. MahantaJ. SultanA.A. SinghN. Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: A malaria elimination point of view Sci Rep 7 1 16690 2017 10.1038/s41598-017-16866-5
- 89.Pérez-Victoria J.M., Bavchvarov B.I., Torrecillas I.R., Martínez-García M., López-Martín C., Campillo M., Castanys S., Gamarro F.: Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania. Antimicrob Agents Chemother. 55(8), 3838–3844 (2011) doi:
10.1128/AAC.00065-11
Pérez-VictoriaJ.M. BavchvarovB.I. TorrecillasI.R. Martínez-GarcíaM. López-MartínC. CampilloM. CastanysS. GamarroF. Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania Antimicrob Agents Chemother 55 8 3838 3844 2011 10.1128/AAC.00065-11
- 90.Perry D., Dixon K., Garlapati R., Gendernalik A., Poché D., Poché R.: Visceral Leishmaniasis Prevalence and Associated Risk Factors in the Saran District of Bihar, India, from 2009 to July of 2011. Am J Trop Med Hyg. 88(4), 778–784 (2013) doi:
10.4269/ajtmh.12-0442
PerryD. DixonK. GarlapatiR. GendernalikA. PochéD. PochéR. Visceral Leishmaniasis Prevalence and Associated Risk Factors in the Saran District of Bihar, India, from 2009 to July of 2011 Am J Trop Med Hyg 88 4 778 784 2013 10.4269/ajtmh.12-0442
- 91.Pinart M., Rueda J.R., Romero G.A., Pinzón-Flórez C.E., Osorio-Arango K., Silveira Maia-Elkhoury A.N., Reveiz L., Elias V.M., Tweed J.A.: Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev. 2020(8), CD004834 92020) doi:
10.1002/14651858.CD004834.pub3
PinartM. RuedaJ.R. RomeroG.A. Pinzón-FlórezC.E. Osorio-ArangoK. Silveira Maia-ElkhouryA.N. ReveizL. EliasV.M. TweedJ.A. Interventions for American cutaneous and mucocutaneous leishmaniasis Cochrane Database Syst Rev 2020 8 CD004834 92020 10.1002/14651858.CD004834.pub3
- 92.Pluijm R.W. van der, Amaratunga C., Dhorda M., Dondorp A.M.: Triple Artemisinin-Based Combination Therapies for Malaria – A New Paradigm? Trends in Parasitology 37(1), 15–24 (2021) doi:
10.1016/j.pt.2020.09.011
PluijmR.W. van der AmaratungaC. DhordaM. DondorpA.M. Triple Artemisinin-Based Combination Therapies for Malaria – A New Paradigm? Trends in Parasitology 37 1 15 24 2021 10.1016/j.pt.2020.09.011
- 93.Ponte-Sucre A., Gamarro F., Dujardin J.C., Barrett M.P., López-Vélez R., García-Hernández R., Pountain A.W., Mwenechanya R., Papadopoulou B.: Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLOS Neglected Tropical Diseases 11(12), e0006052 (2017) doi:
10.1371/journal.pntd.0006052
Ponte-SucreA. GamarroF. DujardinJ.C. BarrettM.P. López-VélezR. García-HernándezR. PountainA.W. MwenechanyaR. PapadopoulouB. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge PLOS Neglected Tropical Diseases 11 12 e0006052 2017 10.1371/journal.pntd.0006052
- 94.Potvin J.E., Leprohon P., Queffeulou M., Sundar S., Ouellette M.: Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani. Clin Infect Dis. 72(10), e526–e532 (2020) doi:
10.1093/cid/ciaa1236
PotvinJ.E. LeprohonP. QueffeulouM. SundarS. OuelletteM. Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani Clin Infect Dis. 72 10 e526 e532 2020 10.1093/cid/ciaa1236
- 95.Pountain A.W., Weidt S.K., Regnault C., Bates P.A., Donachie A.M., Dickens N.J., Barrett M.P.: Genomic instability at the locus of sterol C24-methyltransferase promotes amphotericin B resistance in Leishmania parasites. PLoS Negl Trop Dis. 13(2), e0007052 (2019) doi:
10.1371/journal.pntd.0007052
PountainA.W. WeidtS.K. RegnaultC. BatesP.A. DonachieA.M. DickensN.J. BarrettM.P. Genomic instability at the locus of sterol C24-methyltransferase promotes amphotericin B resistance in Leishmania parasites PLoS Negl Trop Dis. 13 2 e0007052 2019 10.1371/journal.pntd.0007052
- 96.Prusa A.R., Kasper D.C., Pollak A., Olischar M., Gleiss A., Hayde M.: Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program. Clinical Microbiology and Infection. 21(2), 191.e1–191.e8 (2015) doi:
10.1016/j.cmi.2014.09.018
PrusaA.R. KasperD.C. PollakA. OlischarM. GleissA. HaydeM. Amniocentesis for the detection of congenital toxoplasmosis: results from the nationwide Austrian prenatal screening program Clinical Microbiology and Infection. 21 2 191.e1 191.e8 2015 10.1016/j.cmi.2014.09.018
- 97.Pulcini S., Staines H.M., Lee A.H., Shafik S.H., Bouyer G., Moore C.M., Daley D.A., Hoke M.J., Altenhofen L.M., Painter H.J., et al.: Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite’s food vacuole and alter drug sensitivities. Sci Rep. 5(1), 14552 (2015) doi:
10.1038/srep14552
PulciniS. StainesH.M. LeeA.H. ShafikS.H. BouyerG. MooreC.M. DaleyD.A. HokeM.J. AltenhofenL.M. PainterH.J. Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite’s food vacuole and alter drug sensitivities Sci Rep 5 1 14552 2015 10.1038/srep14552
- 98.Reed M.B., Saliba K.J., Caruana S.R., Kirk K., Cowman A.F.: Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature. 403(6772), 906–909 (2000) doi:
10.1038/35002615
ReedM.B. SalibaK.J. CaruanaS.R. KirkK. CowmanA.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum Nature 403 6772 906 909 2000 10.1038/35002615
- 99.Rénia L. and Goh Y.S.: Malaria Parasites: The Great Escape. Front Immunol. 7 (2016) doi: 10.3389/fimmu.2016.00463
- 100.Riches A., Hart C.J.S., Trenholme K.R., Skinner-Adams T.S.: Anti-Giardia Drug Discovery: Current Status and Gut Feelings. J Med Chem. 63(22), 13330–13354 (2020) doi:
10.1021/acs.jmedchem.0c00910
RichesA. HartC.J.S. TrenholmeK.R. Skinner-AdamsT.S. Anti-Giardia Drug Discovery: Current Status and Gut Feelings J Med Chem 63 22 13330 13354 2020 10.1021/acs.jmedchem.0c00910
- 101.Robert-Gangneux F., Murat J.B., Fricker-Hidalgo H., Brenier-Pinchart M.P., Gangneux J.P., Pelloux H.: The placenta: a main role in congenital toxoplasmosis? Trends Parasitol. 27(12), 530–536 (2011) doi:
10.1016/j.pt.2011.09.005
Robert-GangneuxF. MuratJ.B. Fricker-HidalgoH. Brenier-PinchartM.P. GangneuxJ.P. PellouxH. The placenta: a main role in congenital toxoplasmosis? Trends Parasitol 27 12 530 536 2011 10.1016/j.pt.2011.09.005
- 102.Rodrigo C., Rajapakse S., Fernando D.: Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev. 2020(9), CD010458 (2020) doi:
10.1002/14651858.CD010458.pub3
RodrigoC. RajapakseS. FernandoD. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria Cochrane Database Syst Rev 2020 9 CD010458 2020 10.1002/14651858.CD010458.pub3
- 103.Roro G.B., Eriso F., Al-Hazimi A.M., Kuddus M., Singh S.C., Upadhye V., Hajare S.T.: Prevalence and associated risk factors of Entamoeba histolytica infection among school children from three primary schools in Arsi Town, West Zone, Ethiopia. J Parasit Dis. 46(3), 776–784 (2022) doi:
10.1007/s12639-022-01495-1
RoroG.B. ErisoF. Al-HazimiA.M. KuddusM. SinghS.C. UpadhyeV. HajareS.T. Prevalence and associated risk factors of Entamoeba histolytica infection among school children from three primary schools in Arsi Town, West Zone, Ethiopia J Parasit Dis 46 3 776 784 2022 10.1007/s12639-022-01495-1
- SA Maternal & Neonatal Clinical Network. South Australian Perinatal Practice Guidelines toxoplasmosis in pregnancy. (2015)
- 105.Sands M., Kron M.A., Brown R.B.: Pentamidine: A Review. Reviews of Infectious Diseases. 7(5), 625–6344 (1985) doi:
10.1093/clinids/7.5.625
SandsM. KronM.A. BrownR.B. Pentamidine: A Review Reviews of Infectious Diseases 7 5 625 6344 1985 10.1093/clinids/7.5.625
- 106.Sasidharan S. and Saudagar P.: Leishmaniasis: where are we and where are we heading? Parasitol Res. 120(5), 1541–1554 (2021) doi:
10.1007/s00436-021-07139-2
SasidharanS. SaudagarP. Leishmaniasis: where are we and where are we heading? Parasitol Res 120 5 1541 1554 2021 10.1007/s00436-021-07139-2
- 107.Sawyer P.R., Brogden R.N., Pinder R.M., Speight T.M., Avery G.S.: Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy. Drugs. 11(6), 423–440 (1976) doi:
10.2165/00003495-197611060-00003
SawyerP.R. BrogdenR.N. PinderR.M. SpeightT.M. AveryG.S. Tinidazole: a review of its antiprotozoal activity and therapeutic efficacy Drugs 11 6 423 440 1976 10.2165/00003495-197611060-00003
- 108.Schousboe M.L., Ranjitkar S., Rajakaruna R.S., Amerasinghe P.H., Morales F., Pearce R., Ord R., Leslie T., Rowland M., Gadalla N.B, et al. Multiple Origins of Mutations in the mdr1 Gene-A Putative Marker of Chloroquine Resistance in P. vivax. PLOS Neglected Tropical Diseases. 9(11), e0004196 (2015) doi:
10.1371/journal.pntd.0004196
SchousboeM.L. RanjitkarS. RajakarunaR.S. AmerasingheP.H. MoralesF. PearceR. OrdR. LeslieT. RowlandM. GadallaN.B Multiple Origins of Mutations in the mdr1 Gene-A Putative Marker of Chloroquine Resistance in P. vivax PLOS Neglected Tropical Diseases 9 11 e0004196 2015 10.1371/journal.pntd.0004196
- 109.Semedo M.G., Pereira A.L., Pita J.R.: The influence of German science on Cinchona and quinine research in Portugal in the second half of the 19th century. Pharmazie. 76(8), 396–402 (2021) doi:
10.1691/ph.2021.1050
SemedoM.G. PereiraA.L. PitaJ.R. The influence of German science on Cinchona and quinine research in Portugal in the second half of the 19th century Pharmazie 76 8 396 402 2021 10.1691/ph.2021.1050
- 110.Servián A., Helman E., Iglesias M. del R., Panti-May J.A., Zonta M.L., Navone G.T.: Prevalence of Human Intestinal Entamoeba spp. in the Americas: A Systematic Review and Meta-Analysis 1990–2022. Pathogens. 11(11), 1365 (2022) doi:
10.3390/pathogens11111365
ServiánA. HelmanE. IglesiasM. del R. Panti-MayJ.A. ZontaM.L. NavoneG.T. Prevalence of Human Intestinal Entamoeba spp. in the Americas: A Systematic Review and Meta-Analysis 1990–2022 Pathogens 11 11 1365 2022 10.3390/pathogens11111365
- 111.Sharpton T.J., Combrink L., Arnold H.K., Gaulke C.A., Kent M.: Harnessing the Gut Microbiome in the Fight against Anthelminthic Drug Resistance. Curr Opin Microbiol. 53, 26–34 (2020) doi:
10.1016/j.mib.2020.01.017
SharptonT.J. CombrinkL. ArnoldH.K. GaulkeC.A. KentM. Harnessing the Gut Microbiome in the Fight against Anthelminthic Drug Resistance Curr Opin Microbiol 53 26 34 2020 10.1016/j.mib.2020.01.017
- 112.Silva L.A., Reis-Cunha J.L., Bartholomeu D.C., Vítor R.W.A.: Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil. PLOS ONE 12(1), e0170689 (2017) doi:
10.1371/journal.pone.0170689
SilvaL.A. Reis-CunhaJ.L. BartholomeuD.C. VítorR.W.A. Genetic Polymorphisms and Phenotypic Profiles of Sulfadiazine-Resistant and Sensitive Toxoplasma gondii Isolates Obtained from Newborns with Congenital Toxoplasmosis in Minas Gerais, Brazil PLOS ONE 12 1 e0170689 2017 10.1371/journal.pone.0170689
- 113.Singh A., Banerjee T., Shukla S.K., Upadhyay S., Verma A.: Creep in nitroimidazole inhibitory concentration among the Entamoeba histolytica isolates causing amoebic liver abscess and screening of andrographolide as a repurposing drug. Sci Rep. 13(1), 12192 (2023) doi:
10.1038/s41598-023-39382-1
SinghA. BanerjeeT. ShuklaS.K. UpadhyayS. VermaA. Creep in nitroimidazole inhibitory concentration among the Entamoeba histolytica isolates causing amoebic liver abscess and screening of andrographolide as a repurposing drug Sci Rep 13 1 12192 2023 10.1038/s41598-023-39382-1
- 114.Singh A., Houpt E., Petri W.A.: Rapid Diagnosis of Intestinal Parasitic Protozoa, with a Focus on Entamoeba histolytica. Interdisciplinary Perspectives on Infectious Diseases 2009(1), 547090 (2009) doi:
10.1155/2009/547090
SinghA. HouptE. PetriW.A. Rapid Diagnosis of Intestinal Parasitic Protozoa, with a Focus on Entamoeba histolytica Interdisciplinary Perspectives on Infectious Diseases 2009 1 547090 2009 10.1155/2009/547090
- 115.Sosa N., Pascale J.M., Jiménez A.I., Norwood J.A., Kreishman-Detrick M., Weina P.J., Lawrence K., McCarthy W.F., Adams R.C., Scott C., et al. Topical paromomycin for New World cutaneous leishmaniasis. PLoS Negl Trop Dis. 13(5), e0007253 (2019) doi:
10.1371/journal.pntd.0007253
SosaN. PascaleJ.M. JiménezA.I. NorwoodJ.A. Kreishman-DetrickM. WeinaP.J. LawrenceK. McCarthyW.F. AdamsR.C. ScottC. Topical paromomycin for New World cutaneous leishmaniasis PLoS Negl Trop Dis 13 5 e0007253 2019 10.1371/journal.pntd.0007253
- 116.Srivastava S., Mishra J., Gupta A.K., Singh A., Shankar P., Singh S.: Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India. Parasit Vectors. 10, 49 (2017) doi:
10.1186/s13071-017-1969-z
SrivastavaS. MishraJ. GuptaA.K. SinghA. ShankarP. SinghS. Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India Parasit Vectors 10 49 2017 10.1186/s13071-017-1969-z
- 117.Staines H.M., Burrow R., Teo B.H.Y., Chis Ster I., Kremsner P.G., Krishna S.: Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis. J Antimicrob Chemother. 73(3), 581–595 (2018) doi:
10.1093/jac/dkx431
StainesH.M. BurrowR. TeoB.H.Y. Chis SterI. KremsnerP.G. KrishnaS. Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis J Antimicrob Chemother 73 3 581 595 2018 10.1093/jac/dkx431
- 118.Steverding D.: The spreading of parasites by human migratory activities. Virulence. 11(1), 1177–1191 (2020) doi:
10.1080/21505594.2020.1809963
SteverdingD. The spreading of parasites by human migratory activities Virulence 11 1 1177 1191 2020 10.1080/21505594.2020.1809963
- 119.Takala-Harrison S., Jacob C.G., Arze C., Cummings M.P., Silva J.C., Dondorp A.M., Fukuda M.M., Hien T.T., Mayxay M., Noedl H., et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis. 211(5), 670–679 (2015) doi:
10.1093/infdis/jiu491
Takala-HarrisonS. JacobC.G. ArzeC. CummingsM.P. SilvaJ.C. DondorpA.M. FukudaM.M. HienT.T. MayxayM. NoedlH. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia J Infect Dis 211 5 670 679 2015 10.1093/infdis/jiu491
- 120.Tharmaratnam T., Kumanan T., Iskandar M.A., D’Urzo K., Gopee-Ramanan P., Loganathan M., Tabobondung T., Tabobondung T.A., Sivagurunathan S., Patel M., et al. Entamoeba histolytica and amoebic liver abscess in northern Sri Lanka: a public health problem. Trop Med Health. 48(1), 2 (2020) doi:
10.1186/s41182-020-0193-2
TharmaratnamT. KumananT. IskandarM.A. D’UrzoK. Gopee-RamananP. LoganathanM. TabobondungT. TabobondungT.A. SivagurunathanS. PatelM. Entamoeba histolytica and amoebic liver abscess in northern Sri Lanka: a public health problem Trop Med Health 48 1 2 2020 10.1186/s41182-020-0193-2
- 121.Tjitra E., Baker J., Suprianto S., Cheng Q., Anstey N.M.: Therapeutic Efficacies of Artesunate-Sulfadoxine-Pyrimethamine and Chloroquine-Sulfadoxine-Pyrimethamine in Vivax Malaria Pilot Studies: Relationship to Plasmodium vivax dhfr Mutations. Antimicrob Agents Chemother. 46(12), 3947–3953 (2002) doi:
10.1128/AAC.46.12.3947-3953.2002
TjitraE. BakerJ. SupriantoS. ChengQ. AnsteyN.M. Therapeutic Efficacies of Artesunate-Sulfadoxine-Pyrimethamine and Chloroquine-Sulfadoxine-Pyrimethamine in Vivax Malaria Pilot Studies: Relationship to Plasmodium vivax dhfr Mutations Antimicrob Agents Chemother 46 12 3947 3953 2002 10.1128/AAC.46.12.3947-3953.2002
- 122.Torgerson P.R. and Mastroiacovo P.: The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 91(7), 501–508 (2013) doi:
10.2471/BLT.12.111732
TorgersonP.R. MastroiacovoP. The global burden of congenital toxoplasmosis: a systematic review Bull World Health Organ 91 7 501 508 2013 10.2471/BLT.12.111732
- Tripathi L.K., Nailwal T.K.: Chapter 1 – Leishmaniasis: an overview of evolution, classification, distribution, and historical aspects of parasite and its vector. In: Samant M, Chandra Pandey S, editors. Pathogenesis, Treatment and Prevention of Leishmaniasis. Academic Press. p. 1–25 (2021)
https://www.sciencedirect.com/science/article/pii/B9780128228005000044 - 124.Tse E.G., Korsik M., Todd M.H.: The past, present and future of antimalarial medicines. Malaria Journal. 18(1), 93 (2019) doi:
10.1186/s12936-019-2724-z
TseE.G. KorsikM. ToddM.H. The past, present and future of antimalarial medicines Malaria Journal 18 1 93 2019 10.1186/s12936-019-2724-z
- 125.Ungogo M.A., Campagnaro G.D., Alghamdi A.H., Natto M.J., de Koning H.P.: Differences in Transporters Rather than Drug argets Are the Principal Determinants of the Different Innate Sensitivities of Trypanosoma congolense and Trypanozoon Subgenus Trypanosomes to Diamidines and Melaminophenyl Arsenicals. International Journal of Molecular Sciences 23(5), 2844 (2022) doi:
10.3390/ijms23052844
UngogoM.A. CampagnaroG.D. AlghamdiA.H. NattoM.J. de KoningH.P. Differences in Transporters Rather than Drug argets Are the Principal Determinants of the Different Innate Sensitivities of Trypanosoma congolense and Trypanozoon Subgenus Trypanosomes to Diamidines and Melaminophenyl Arsenicals International Journal of Molecular Sciences 23 5 2844 2022 10.3390/ijms23052844
- 126.Waithera M.W., Sifuna M.W., Kimani S.K., Takei M.:. Drug selection pressure and fitness cost for artemether-resistant Plasmodium berghei ANKA parasites in vivo. International Journal of Antimicrobial Agents 62(6), 107012 (2023) doi:
10.1016/j.ijantimicag.2023.107012
WaitheraM.W. SifunaM.W. KimaniS.K. TakeiM. Drug selection pressure and fitness cost for artemether-resistant Plasmodium berghei ANKA parasites in vivo International Journal of Antimicrobial Agents 62 6 107012 2023 10.1016/j.ijantimicag.2023.107012
- WHO. 2020. Sustained decline in sleeping sickness cases puts elimination within reach. [accessed 2024 Oct 4].
https://www.who.int/news/item/23-06-2020-sustained-decline-in-sleeping-sickness-cases-puts-elimination-within-reach . - 128.Wicht K.J., Mok S., Fidock D.A.: Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria. Annual Review of Microbiology. 74, 431–454 (2020) doi:
10.1146/annurev-micro-020518-115546
WichtK.J. MokS. FidockD.A. Molecular Mechanisms of Drug Resistance in Plasmodium falciparum Malaria Annual Review of Microbiology. 74 431 454 2020 10.1146/annurev-micro-020518-115546
- 129.Wijnant G.J, Dumetz F., Dirkx L., Bulté D., Cuypers B., Van Bocxlaer K., Hendrickx S.: Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis. Front Trop Dis. 3 (2022) doi:
10.3389/fitd.2022.837460
WijnantG.J DumetzF. DirkxL. BultéD. CuypersB. Van BocxlaerK. HendrickxS. Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis Front Trop Dis 3 2022 10.3389/fitd.2022.837460
- WHO. 2024a. Leishmaniasis. [accessed 2024 Aug 26].
https://www.who.int/news-room/fact-sheets/detail/leishmaniasis . - WHO. 2024b. Guidelines for the treatment of human African trypanosomiasis.[accessed 2024 Sep 3].
https://www.who.int/publications/i/item/9789240096035 . - WHO. 2023. World Malaria Report 2023. [accessed 2024 Aug 26].
https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023 . - 133.Xie S.C., Ralph S.A., Tilley L.:. K13, the Cytostome, and Artemisinin Resistance. Trends Parasitol. 36(6), 533–544 (2020) doi:
10.1016/j.pt.2020.03.006
XieS.C. RalphS.A. TilleyL. K13, the Cytostome, and Artemisinin Resistance Trends Parasitol 36 6 533 544 2020 10.1016/j.pt.2020.03.006
- 134.Yoshida N., Yamauchi M., Morikawa R., Hombhanje F., Mita T.: Increase in the proportion of Plasmodium falciparum with kelch13 C580Y mutation and decline in pfcrt and pfmdr1 mutant alleles in Papua New Guinea. Malar J. 20(1), 410 (2021) doi:
10.1186/s12936-021-03933-6
YoshidaN. YamauchiM. MorikawaR. HombhanjeF. MitaT. Increase in the proportion of Plasmodium falciparum with kelch13 C580Y mutation and decline in pfcrt and pfmdr1 mutant alleles in Papua New Guinea Malar J 20 1 410 2021 10.1186/s12936-021-03933-6
- 135.Zajaczkowski P., Lee R., Fletcher-Lartey S.M., Alexander K., Mahimbo A., Stark D., Ellis J.T.: The controversies surrounding Giardia intestinalis assemblages A and B. Current Research in Parasitology & VectorBorne Diseases 1, 100055 (2021) doi:
10.1016/j.crpvbd.2021.100055
ZajaczkowskiP. LeeR. Fletcher-LarteyS.M. AlexanderK. MahimboA. StarkD. EllisJ.T. The controversies surrounding Giardia intestinalis assemblages A and B Current Research in Parasitology & VectorBorne Diseases 1 100055 2021 10.1016/j.crpvbd.2021.100055
- 136.Zoltner M., Campagnaro G.D., Taleva G., Burrell A., Cerone M., Leung K.F., Achcar F., Horn D., Vaughan S., Gadelha C., et al. Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes. Journal of Biological Chemistry. 295(24), 8331–8347 (2020) doi:
10.1074/jbc.RA120.012355
ZoltnerM. CampagnaroG.D. TalevaG. BurrellA. CeroneM. LeungK.F. AchcarF. HornD. VaughanS. GadelhaC. Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes Journal of Biological Chemistry 295 24 8331 8347 2020 10.1074/jbc.RA120.012355